CYP24A1 Gene Hypercalcemia Infantile Type Genetic Test sale cost 4400 AED
COG6 Gene Glycosylation Disorder Type 3 Genetic Test sale cost 4400 AED COG6 Gene Glycosylation Disorder Type 3 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
LPL Gene Hyperlipoproteinemia Type 1 Genetic Test sale cost 4400 AED LPL Gene Hyperlipoproteinemia Type 1 Genetic Test Cost 5,600 د.إ Original price was: 5,600 د.إ.4,400 د.إCurrent price is: 4,400 د.إ.
Sale!

CYP24A1 Gene Hypercalcemia Infantile Type Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The “CYP24A1 Gene Hypercalcemia Infantile Type Genetic Test” is a specialized diagnostic tool designed to identify mutations in the CYP24A1 gene, which are known to cause infantile hypercalcemia. This condition is characterized by abnormally high levels of calcium in the blood during infancy, which can lead to various health complications if left untreated. The test is crucial for early detection, enabling timely intervention and management strategies to mitigate potential health issues associated with the condition.

Performed at DNA Labs UAE, the test involves analyzing the patient’s DNA to look for specific genetic mutations in the CYP24A1 gene. These mutations disrupt the normal breakdown of vitamin D, leading to increased calcium absorption and hypercalcemia. Identifying these mutations can help in confirming the diagnosis, understanding the severity of the condition, and guiding treatment decisions.

The cost of the test is 4400 AED, reflecting the specialized nature of the genetic analysis and the expertise required to interpret the results accurately. Given the implications of early detection on the patient’s health outcomes, the test represents a critical investment in the health and well-being of infants suspected of having this genetic condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

CYP24A1 Gene Hypercalcemia infantile type Genetic Test

Components: CYP24A1 gene hypercalcemia infantile type NGS genetic test

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for CYP24A1 Gene Hypercalcemia infantile type NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Hypercalcemia infantile type.

Test Details

The CYP24A1 gene hypercalcemia infantile type NGS genetic test is a genetic test that analyzes the CYP24A1 gene for mutations that are associated with hypercalcemia in infants. Hypercalcemia is a condition characterized by high levels of calcium in the blood, which can lead to various symptoms and complications.

The CYP24A1 gene provides instructions for producing an enzyme called 25-hydroxyvitamin D 24-hydroxylase, which plays a crucial role in regulating calcium levels in the body. Mutations in the CYP24A1 gene can impair the function of this enzyme, leading to an imbalance in calcium levels and causing hypercalcemia.

NGS (Next-Generation Sequencing) technology is used in this genetic test to analyze the entire coding region of the CYP24A1 gene. This advanced sequencing technique allows for the detection of various types of mutations, including small insertions, deletions, and single nucleotide variants.

By identifying mutations in the CYP24A1 gene, this genetic test can help in the diagnosis and management of hypercalcemia in infants. It can also provide information about the inheritance pattern of the condition, allowing for genetic counseling and family planning.

It is important to note that this genetic test is typically ordered by healthcare professionals who specialize in genetics or endocrinology. The results of the test should be interpreted by a qualified healthcare provider who can provide appropriate counseling and guidance based on the individual’s specific situation.

Test Name CYP24A1 Gene Hypercalcemia infantile type Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for CYP24A1 Gene Hypercalcemia infantile type NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Hypercalcemia infantile type
Test Details

CYP24A1 gene hypercalcemia infantile type NGS genetic test is a genetic test that analyzes the CYP24A1 gene for mutations that are associated with hypercalcemia in infants. Hypercalcemia is a condition characterized by high levels of calcium in the blood, which can lead to various symptoms and complications.

The CYP24A1 gene provides instructions for producing an enzyme called 25-hydroxyvitamin D 24-hydroxylase, which plays a crucial role in regulating calcium levels in the body. Mutations in the CYP24A1 gene can impair the function of this enzyme, leading to an imbalance in calcium levels and causing hypercalcemia.

NGS (Next-Generation Sequencing) technology is used in this genetic test to analyze the entire coding region of the CYP24A1 gene. This advanced sequencing technique allows for the detection of various types of mutations, including small insertions, deletions, and single nucleotide variants.

By identifying mutations in the CYP24A1 gene, this genetic test can help in the diagnosis and management of hypercalcemia in infants. It can also provide information about the inheritance pattern of the condition, allowing for genetic counseling and family planning.

It is important to note that this genetic test is typically ordered by healthcare professionals who specialize in genetics or endocrinology. The results of the test should be interpreted by a qualified healthcare provider who can provide appropriate counseling and guidance based on the individual’s specific situation.

SKU: TEST-2425 Category:

Related products